Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Current Urology Reports|November 16, 2004
A case for botulinum toxin-A in idiopathic bladder overactivityChristopher P Smith, George T Somogyi, Michael B Chancellor, et al.
International Urogynecology Journal|August 8, 2020
High-density surface electromyographic assessment of pelvic floor hypertonicity in IC/BPS patients: a pilot studyNicholas Dias, Chuan Zhang, Christopher P Smith, et al.
Acta Medica Okayama|April 11, 2003
Botulinum toxin treatment of urethral and bladder dysfunctionTeruhiko Yokoyama, Hiromi Kumon, Christopher P Smith, et al.
Neurochemistry International|September 1, 2004
Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injuryMohit Khera, George T Somogyi, Susanna Kiss, et al.
Neurourology and Urodynamics|September 13, 2007
Comparison of cystometric methods in female ratsPhillip P Smith, Eric Hurtado, Christopher P Smith, et al.
Obstetrics and Gynecology|October 15, 2016
Chylous Ascites Complicating Modified Radical Hysterectomy for Placenta PercretaHeather Miller, Matthew L Anderson, Christopher P Smith, et al.
Brain Research Bulletin|June 22, 2011
Plasticity of non-adrenergic non-cholinergic bladder contractions in rats after chronic spinal cord injuryH Henry Lai, Alvaro Munoz, Christopher P Smith, et al.
Neurochemistry International|June 23, 2005
Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin AChristopher P Smith, Vijaya M Vemulakonda, Susanna Kiss, et al.
BMC Urology|May 26, 2010
Removal of urothelium affects bladder contractility and release of ATP but not release of NO in rat urinary bladderAlvaro Munoz, David A Gangitano, Christopher P Smith, et al.
BJU International|May 1, 2012
Modulation of bladder afferent signals in normal and spinal cord-injured rats by purinergic P2X3 and P2X2/3 receptorsAlvaro Munoz, George T Somogyi, Timothy B Boone, et al.
Pageof 7